UK markets close in 2 hours 33 minutes

Biofrontera AG (B8F.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
0.3780+0.0280 (+9.52%)
As of 02:14PM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 22.33M
Enterprise value 20.11M
Trailing P/E 125.80
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.79
Price/book (mrq)1.61
Enterprise value/revenue 0.70
Enterprise value/EBITDA -2.83

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-69.70%
S&P500 52-week change 322.43%
52-week high 31.1800
52-week low 30.2820
50-day moving average 30.3405
200-day moving average 30.4793

Share statistics

Avg vol (3-month) 310.86k
Avg vol (10-day) 312.32k
Shares outstanding 563.81M
Implied shares outstanding 663.81M
Float 810.05M
% held by insiders 167.60%
% held by institutions 10.01%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -1.14%
Operating margin (ttm)8.75%

Management effectiveness

Return on assets (ttm)9.42%
Return on equity (ttm)-1.83%

Income statement

Revenue (ttm)32.25M
Revenue per share (ttm)0.87
Quarterly revenue growth (yoy)94.50%
Gross profit (ttm)N/A
EBITDA 5.57M
Net income avi to common (ttm)-369k
Diluted EPS (ttm)-0.1000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.08M
Total cash per share (mrq)0.08
Total debt (mrq)1.15M
Total debt/equity (mrq)5.74%
Current ratio (mrq)1.76
Book value per share (mrq)0.22

Cash flow statement

Operating cash flow (ttm)-1.91M
Levered free cash flow (ttm)-1.44M